Skip to main content
Clinical Trials/CTRI/2018/02/011813
CTRI/2018/02/011813
Completed
未知

Randomized Double Blind Controlled Trial of Lurasidone versus Risperidone in Schizophrenia

Department of Pharmacology and therapeutics0 sites54 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Pharmacology and therapeutics
Enrollment
54
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 10, 2017
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Pharmacology and therapeutics

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Schizophrenia as per ICD\-10, DCR, Patients aged between 18 to 50 years, Not on any antipsychotic for last three months, Total duration of illness less than one year, Availability of a reliable informant, Written informed consent from the patient/legally acceptable representative

Exclusion Criteria

  • Positive and Negative Syndrome Scale (PANSS) score \<80 or \>120, Presence of any other major psychiatric disorder, except nicotine dependence, Patients at risk for harm to self or others, Established treatment resistance for schizophrenia, Pregnant and lactating females, Clinical situations requiring drugs which are CYP 3A4/2D6 inhibitors or inducers, Clinical situations requiring alternative drugs or interventions eg injectable antipsychotics, ECTs, change of therapy etc., or worsening of symptoms, Patients having any major medical/surgical illness or any clinically significant abnormality in baseline investigations, Patient on any other concomitant drugs that might alter serum interleukin levels

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Double blind randomised controlled trial of Levosimendan versus Dopexamine in septic shockSeptic Shock
EUCTR2004-004384-29-GBDr GED DEMPSEY, University Hospital Aintree20
Completed
Phase 2
Evaluation of Sildenafil and placebo effects on improvement of clinical and paraclinical measures on patients with severe heart failureCondition 1: Ischemic cardiomyopathy. Condition 2: Dilated cardiomyopathy.Ischaemic cardiomyopathyCongestive cardiomyopathy
IRCT201101045544N1Vice chancellor for research shahid Rajaee research center200
Completed
Phase 4
Comparing Salivary Levels of TNF alpha in Patients with Oral Lichen Planus Treated with Topical Clobetasol Propionate and Fluocinolone Acetonidepatients with oral lichen planusOral Lichen Planus, Clobetasol Propionate, Fluocinolone Acetonide, Topical steroid,TNF alpha
TCTR20220705003Faculty of Dentistry Chiang Mai university ,Chiang Mai, Thailand26
Recruiting
Phase 1
Intraoperative pillar corticosteroid injection Does it improve the patient satisfaction after carpal tunnel surgery? Randomized controlled trial, Double blind studyCarpal tunnel syndromePillar corticosteroid injectionCarpal tunnel releasePillar pain
TCTR20211130003Chakrinaruebodindra medical institute84
Enrolling By Invitation
Phase 1
Efficacy of night splint position in Giovanni position compare with Traditional position on acute plantar fasciitis treatmentight splint is the treatment options in patient with acute plantar fasciitis that is not improve with conservative treatmentNight splint, traditional position, digiovanni position, fiberglass night splint
TCTR20220310001Faculty of Medicine, Prince of Songkla University48